iRadimed Corp.
Key Metrics
- Previous Close
- $87.40
- 52-Week Range
- $67.84 – $107.90
- Market Cap
- $1.11B
- P/E (TTM)
- 48.42
- EPS (TTM)
- 1.79
- Dividend Yield
- 0.91%
Advanced Metrics
- Price/Book
- 10.89
- PEG Ratio
- —
- Return on Equity
- 23.52%
- Return on Assets
- 15.56%
- Gross Margin
- 75.86%
- Operating Margin
- 31.23%
- Profit Margin
- 26.70%
- Current Ratio
- 9.46
- Debt/Equity
- —
- Total Debt
- $0.00
- Free Cash Flow
- $16.20M
- Revenue Growth
- 0.30%
- Earnings Growth
- -9.30%
- Enterprise Value
- $1.06B
Market Snapshot
About
iRadimed Corporation develops, manufactures, and distributes magnetic resonance imaging (MRI) compatible medical devices. The company's flagship products include MRI-compatible intravenous (IV) infusion pump systems and patient vital signs monitoring systems. These specialized devices allow healthcare providers to safely deliver medications and monitor patients during MRI procedures without interrupting scans. iRadimed's products address a critical need in medical imaging, as traditional electronic medical devices cannot safely operate in the strong magnetic fields of MRI machines. The company serves hospitals and imaging centers worldwide.